Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Ipsen Pharma SAS

Home Clinical Trial Sponsors and OrganizationsIpsen Pharma SAS

Ipsen Pharma SAS

ACTIVE

Unknown Belgian address 0, Unknown, Belgiumwww.ipsen.comSubsidiary

Part of Ipsen SA

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

65

57 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

28

43.1%

Phase 3

5

7.7%

Phase 3 4

1

1.5%

Trial Status Distribution

Active, not recruiting

57

87.7%

Completed

8

12.3%

Clinical Trials

Trials sponsored by this organization (65)

Effects of triptorelin when given every 6-months under the skin to adult males with cancer in the prostate

Active, not recruiting

Jun 2022145 participants

Effects of triptorelin when given every 6-months under the skin to adult males with cancer in the prostate

Active, not recruiting

May 2022147 participants

Effects of triptorelin when given every 6-months under the skin to adult males with cancer in the prostate

Active, not recruiting

May 2022145 participants

Effects of triptorelin when given every 6-months under the skin to adult males with cancer in the prostate

Active, not recruiting

Apr 2022153 participants

A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged >=14 Years with Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.

Active, not recruiting

Nov 202187 participants

A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged =14 Years with Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.

Active, not recruiting

Nov 202187 participants

COMPARAISON OF THE EFFICACY, SAFETY AND TOLERABILITY OF EZICLEN¿/IZINOVA¿ VERSUS KLEAN-PREP¿ ON BOWEL CLEANSING IN ADOLESCENTS AGED 12-17 YEARS >40 KG UNDERGOING COLONOSCOPY.

Active, not recruiting

Jan 2021250 participants

A PHASE 3, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, MULTI-CENTER, STUDY OF THE EFFICACY AND SAFETY OF LANREOTIDE AUTOGEL/ DEPOT 120 MG PLUS BSC VS. PLACEBO PLUS BSC FOR TUMOR CONTROL IN SUBJECTS WITH WELL DIFFERENTIATED, METASTATIC AND/OR UNRESECTABLE TYPICAL OR ATYPICAL LUNG NEUROENDOCRINE TUMORS

Active, not recruiting

Nov 2020216 participants

Page 1 of 9

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials65
Approvals
News

Back to Organizations